A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Episode 5
Optimizing Molecular Profiling for B-ALL Treatment
Experts discuss the timing and process of obtaining molecular profiles for genetic variants and T-cell biomarkers during patient assessment, including the team member responsible for ordering the test and whether Moffitt Cancer Center uses a preferred assay for adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL).
Video Player is loading.
Video content above is prompted by the following:
In the course of patient assessment, when do you obtain a molecular profile for genetic variants and T-cell biomarkers?
- Which team member obtains or orders the test?
- Does Moffitt Cancer Center use a preferred assay for its adult patients with relapsed or refractory B-ALL?